Literature DB >> 12827265

[Stage 3 recommendations--the early recognition of breast cancer in Germany. Abridged version for medical practitioners].

K-D Schulz1, R Kreienberg, R Fischer, U-S Albert.   

Abstract

The Aim of this level 3 good clinical practice guideline is to help physicians, women and patients in decision making about the appropriate health care for early detection of breast cancer. The principle of early detection of breast cancer comprise the detection and diagnosis of premalignant breast tumors (stage 0, Carcinoma in situ), risk reduction of cancer development as well as the detection and diagnosis of breast cancer at an early stage (stage I), with a 90% chance of cure as shown by a large number of clinical trials. To establish a nation wide, comprehensive quality assuring program for the early detection of breast cancer the guideline summarized in the following paper offers the basis for a timely mortality reduction of breast cancer. The cure of early stage disease will be additionally possible by less invasive treatment allowing patients to maintain quality of life. The guideline leads to a major improvement of women's health care.

Entities:  

Mesh:

Year:  2003        PMID: 12827265     DOI: 10.1007/s00117-003-0915-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  6 in total

1.  Breast Centers in Germany.

Authors:  Ute-Susann Albert; Uwe Wagner; Matthias Kalder
Journal:  Breast Care (Basel)       Date:  2009-08-14       Impact factor: 2.860

2.  Role of Breast Ultrasound for the Detection and Differentiation of Breast Lesions.

Authors:  Helmut Madjar
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

3.  Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival.

Authors:  Christian O Jacke; Ute S Albert; Iris Reinhard; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-16       Impact factor: 4.553

Review 4.  [Oncologic screening with whole-body MRI: possibilities and limitations].

Authors:  J F Schäfer; A Fischmann; M Lichy; J Vollmar; M Fenchel; C D Claussen; H-P Schlemmer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

5.  The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients.

Authors:  Christian O Jacke; Ute S Albert; Matthias Kalder
Journal:  BMC Cancer       Date:  2015-10-19       Impact factor: 4.430

6.  Vacuum-assisted breast biopsy: a comparison of 11-gauge and 8-gauge needles in benign breast disease.

Authors:  Markus Hahn; Stella Okamgba; Peter Scheler; Klaus Freidel; Gerald Hoffmann; Bernhard Kraemer; Diethelm Wallwiener; Ute Krainick-Strobel
Journal:  World J Surg Oncol       Date:  2008-05-19       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.